scispace - formally typeset
J

Joffre B. Baker

Researcher at University of California, San Diego

Publications -  8
Citations -  562

Joffre B. Baker is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Thrombin & Receptor. The author has an hindex of 7, co-authored 8 publications receiving 562 citations.

Papers
More filters
Journal ArticleDOI

Dexamethasone modulates binding and action of epidermal growth factor in serum-free cell culture

TL;DR: Experiments probing the mechanism by which glucocorticoids modulate cell proliferation were carried out on serum-free cell cultures of quiescent human diploid foreskin (HF) cells, suggesting a relationship between the dexamethasone effects on binding and growth.

Released protease-nexin regulates cellular binding, internalization, and degradation of serine proteases (thrombin/urinary plasminogen activator/endocytosis inhibitor/heparin/antithrombin Ill)

TL;DR: In this article, the authors explored the function of PN by examining the interaction of protease-PN complexes with human fibroblasts and the conse- quences of this interaction.
Journal ArticleDOI

Inhibition of tumor-cell-mediated extracellular matrix destruction by a fibroblast proteinase inhibitor, protease nexin I.

TL;DR: It is shown that protease nexin I (PNI), a fibroblast-secreted inhibitor of urokinase, plasmin, and certain other serine proteinases, effectively inhibited the HT-1080 cell-mediated degradation of this ECM.
Journal ArticleDOI

Molecular Cloning and Expression of Two Forms of Human Protease Nexin I

TL;DR: The isolation, sequence, and expression of PNI cDNA cloned from a human foreskin fibroblast cDNA library is described and the amino acid sequence of βPNI is identical to that of a recently described glial–derived neurite promoting factor.
Journal ArticleDOI

Turnover of molecules which maintain the normal surfaces of contact-inhibited cells.

TL;DR: In confluent cultures normal chick embryo fibroblasts become highty agglutinable by concanavalin A within 6 hours after their synthesis of protein is inhibited by cycloheximide, pactamycin, or emetine, but when growing cells are similarly treated, they fail to become more agglUTinable.